SCHEMBL16495677

SCHEMBL16495677

COc1ccc(Oc2c(Cl)cc(C=NO)cc2Cl)cc1Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
NFKB1 P19838 3/20 0.47
NFKB2 Q00653 3/20 0.47
RELA Q04206 3/20 0.47
HSD17B10 Q99714 1/20 0.46
ALDH1A1 P00352 5/20 0.46
CYP1A2 P05177 3/20 0.46
CYP3A4 P08684 3/20 0.46
CYP2C19 P33261 3/20 0.46
PKM P14618 2/20 0.46
HTT P42858 3/20 0.45
THRB P10828 2/20 0.43
RORC P51449 2/20 0.43
MAPT P10636 5/20 0.43
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
LMNA P02545 3/20 0.43
HSP90AA1 P07900 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16495676 1.00 NPC1 (0.47) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL16495779 0.87 ALDH1A1 (0.52) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL16495780 0.87 ALDH1A1 (0.52) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL16496798 0.86 CYP1A2 (0.46) ALDH1A1CYP1A2CYP2C19THRBRORC
SCHEMBL2170803 0.82 LMNA (0.43) NPC1RAB9ASMN1; SMN2ALDH1A1HTT
SCHEMBL2170800 0.82 LMNA (0.43) NPC1RAB9ASMN1; SMN2ALDH1A1HTT
SCHEMBL18932876 0.82 THRB (0.45) ALDH1A1THRBRORCMEN1KMT2A
SCHEMBL18932867 0.77 MAPT (0.46) NPC1RAB9ASMN1; SMN2ALDH1A1CYP1A2
SCHEMBL2169380 0.76 RORC (0.65) HSD17B10ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL2169378 0.76 RORC (0.65) HSD17B10ALDH1A1CYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110301200-A1 THYROID RECEPTOR LIGANDS CADILA HEALTHCARE LIMITED (IN) 2011-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110301200-A1 THYROID RECEPTOR LIGANDS TSHR, THRB, THRA NPC1 2363/4885RAB9A 2182/4885SMN1; SMN2 4824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.